MIRM Latest Headlines

Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), Kazia Therapeutics (KZIA)

at www.tipranks.com (Thu, 22-Oct 6:30 AM)

TD Cowen Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)

at www.tipranks.com (Wed, 21-Oct 8:57 AM)

Mirum sets October 12 investor call to reveal Phase 3 EXPAND topline results for LIVMARLI in ultra-rare cholestatic liver diseases

Market Chameleon (Mon, 12-Oct 11:45 AM)

Mirum Pharmaceuticals sets October 12 investor call to share Phase 3 EXPAND topline results for LIVMARLI in ultra-rare cholestatic liver diseases

Market Chameleon (Mon, 12-Oct 7:07 AM)

Mirum’s brelovitug clears AZURE-1 Phase 3 primary endpoint, with 0% response in delayed-treatment arm

Market Chameleon (Mon, 28-Sep 8:17 AM)